163 related articles for article (PubMed ID: 36004348)
1. Total tumor diameter is a better indicator of multifocal papillary thyroid microcarcinoma: A propensity score matching analysis.
Jiang KC; Lin B; Zhang Y; Zhao LQ; Luo DC
Front Endocrinol (Lausanne); 2022; 13():974755. PubMed ID: 36004348
[TBL] [Abstract][Full Text] [Related]
2. Total tumor diameter: the neglected value in papillary thyroid microcarcinoma.
Feng JW; Pan H; Wang L; Ye J; Jiang Y; Qu Z
J Endocrinol Invest; 2020 May; 43(5):601-613. PubMed ID: 31749082
[TBL] [Abstract][Full Text] [Related]
3. The value of total tumor diameter in unilateral multifocal papillary thyroid carcinoma: a propensity score matching analysis.
Wu ZJ; Xia BY; Chen ZW; Gong H; Abuduwaili M; Xing ZC; Su AP
Front Endocrinol (Lausanne); 2023; 14():1217613. PubMed ID: 37745721
[TBL] [Abstract][Full Text] [Related]
4. Does Multifocal Papillary Thyroid Microcarcinoma With a Total Tumor Diameter >1 cm Indicate Poor Biological Behavior? The Evidence is Insufficient.
Zhou B; Wei L; Qin J
Endocr Pract; 2021 Feb; 27(2):131-136. PubMed ID: 33547013
[TBL] [Abstract][Full Text] [Related]
5. SHOULD MULTIFOCAL PAPILLARY THYROID CARCINOMAS CLASSIFIED AS T1A WITH A TUMOR DIAMETER SUM OF 1 TO 2 CENTIMETERS BE RECLASSIFIED AS T1B?
Tam AA; Ozdemir D; Ogmen BE; Fakı S; Dumlu EG; Yazgan AK; Ersoy R; Cakır B
Endocr Pract; 2017 May; 23(5):526-535. PubMed ID: 28156153
[TBL] [Abstract][Full Text] [Related]
6. Association of multifocality, tumor number, and total tumor diameter with clinicopathological features in papillary thyroid cancer.
Tam AA; Özdemir D; Çuhacı N; Başer H; Aydın C; Yazgan AK; Ersoy R; Çakır B
Endocrine; 2016 Sep; 53(3):774-83. PubMed ID: 27090526
[TBL] [Abstract][Full Text] [Related]
7. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
8. Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma.
Zhao Q; Ming J; Liu C; Shi L; Xu X; Nie X; Huang T
Ann Surg Oncol; 2013 Mar; 20(3):746-52. PubMed ID: 22972508
[TBL] [Abstract][Full Text] [Related]
9. Bilateral multifocality, a marker for aggressive disease, is not an independent prognostic factor for papillary thyroid microcarcinoma: A propensity score matching analysis.
Yan T; Qiu W; Song J; Ying T; Fan Y; Yang Z
Clin Endocrinol (Oxf); 2021 Jul; 95(1):209-216. PubMed ID: 33660317
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of radiofrequency ablation for multifocal papillary thyroid microcarcinoma versus unifocal papillary thyroid microcarcinoma: a propensity-matched cohort study.
Yan L; Zhang M; Song Q; Xie F; Luo Y
Eur Radiol; 2022 Feb; 32(2):1216-1226. PubMed ID: 34357450
[TBL] [Abstract][Full Text] [Related]
11. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.
Yuan J; Li J; Chen X; Lin X; Du J; Zhao G; Chen Z; Wu Z
Bull Cancer; 2017 Jun; 104(6):516-523. PubMed ID: 28476312
[TBL] [Abstract][Full Text] [Related]
12. Total tumour diameter is superior to unifocal diameter as a predictor of papillary thyroid microcarcinoma prognosis.
Liu C; Wang S; Zeng W; Guo Y; Liu Z; Huang T
Sci Rep; 2017 May; 7(1):1846. PubMed ID: 28500312
[TBL] [Abstract][Full Text] [Related]
13. Does total tumour diameter, multifocality, number of tumour foci, or laterality predict lymph node metastasis or recurrence in differentiated thyroid cancer?
Elbasan O; Ilgın C; Gogas Yavuz D
Endokrynol Pol; 2023; 74(2):153-167. PubMed ID: 37039491
[TBL] [Abstract][Full Text] [Related]
14. Clinical and pathologic predictors of central lymph node metastasis in papillary thyroid microcarcinoma: a retrospective cohort study.
Gui CY; Qiu SL; Peng ZH; Wang M
J Endocrinol Invest; 2018 Apr; 41(4):403-409. PubMed ID: 28884301
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients.
Zhang L; Wei WJ; Ji QH; Zhu YX; Wang ZY; Wang Y; Huang CP; Shen Q; Li DS; Wu Y
J Clin Endocrinol Metab; 2012 Apr; 97(4):1250-7. PubMed ID: 22319042
[TBL] [Abstract][Full Text] [Related]
16. Which papillary thyroid microcarcinoma should be treated as "true cancer" and which as "precancer"?
Kaliszewski K; Diakowska D; Wojtczak B; Forkasiewicz Z; Pupka D; Nowak Ł; Rudnicki J
World J Surg Oncol; 2019 May; 17(1):91. PubMed ID: 31146753
[TBL] [Abstract][Full Text] [Related]
17. Extent of Surgery and the Prognosis of Unilateral Papillary Thyroid Microcarcinoma.
Zhao H; Cui L
Front Endocrinol (Lausanne); 2021; 12():655608. PubMed ID: 34220708
[TBL] [Abstract][Full Text] [Related]
18. Comparison of clinicopathological features and prognosis of papillary thyroid carcinoma and microcarcinoma: A population-based propensity score matching analysis.
Qian B; Hu L; Zhang S; Zhu J; Mei L; Huang T; Qu X
Front Endocrinol (Lausanne); 2022; 13():944758. PubMed ID: 35992148
[TBL] [Abstract][Full Text] [Related]
19. Management of cN0 papillary thyroid microcarcinoma patients according to risk-scoring model for central lymph node metastasis and predictors of recurrence.
Feng JW; Ye J; Wu WX; Qu Z; Qin AC; Jiang Y
J Endocrinol Invest; 2020 Dec; 43(12):1807-1817. PubMed ID: 32557354
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological Findings Associated With Cervical Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Retrospective Study in China.
Shi Y; Yang Z; Heng Y; Ju H; Pan Y; Zhang Y
Cancer Control; 2022; 29():10732748221084926. PubMed ID: 35285273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
